Search Count: 7
![]()  | 
								
									 Human Aldose Reductase In Complex With A Ligand With A Fluoro-Indol-Acetic-Acid Structure (Schl44172) 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:0.97 Å Release Date: 2023-11-15 Classification: OXIDOREDUCTASE Ligands: NAP, QXO, DMS, CIT, PEG  | 
							
![]()  | 
								
									 Human Aldose Reductase Complexed With Schl12134 (3-[5-(3-Nitrophenyl)-2-Thienyl]Propanoic Acid) At 1.02 A 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:1.02 Å Release Date: 2016-03-23 Classification: OXIDOREDUCTASE Ligands: NAP, 53N  | 
							
![]()  | 
								
									
									 
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:1.06 Å Release Date: 2015-04-08 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: NAP, 2W8  | 
							
![]()  | 
								
									 Human Aldose Reductase Complexed With Schl7815 ((3-[3-(5-Nitrofuran-2-Yl)Phenyl]Propanoic Acid)At 1.01 A 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:1.01 Å Release Date: 2015-04-08 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: NAP, 2W9  | 
							
![]()  | 
								
									 Human Aldose Reductase Complexed With Schl12221 ({2-[5-(3-Nitrophenyl)Furan-2-Yl]Phenyl}Acetic Acid) At 0.96 A 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:0.96 Å Release Date: 2015-04-08 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: NAP, 2WB  | 
							
![]()  | 
								
									
									 
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2015-03-04 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: 2HZ, NAP  | 
							
![]()  | 
								
									
									 
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2009-04-07 Classification: OXIDOREDUCTASE Ligands: NAP, 53N  | 
							
					






